Sign Up to like & get
recommendations!
0
Published in 2025 at "Cancer immunology research"
DOI: 10.1158/2326-6066.cir-24-0589
Abstract: Despite the pivotal role of cytotoxic T lymphocytes (CTLs) in anti-tumor immunity, a substantial proportion of CTL-rich hepatocellular carcinoma (HCC) patients experience early relapse or immunotherapy resistance. However, spatial immune variations impacting the heterogeneous clinical…
read more here.
Keywords:
ctl rich;
hepatocellular carcinoma;
rich hepatocellular;
hccs ... See more keywords